# The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus

> **NCT01092663** · NA · COMPLETED · sponsor: **KineMed** · enrollment: 61 (actual)

## Conditions studied

- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** Colesevelam HCl
- **DRUG:** Sitagliptin

## Key facts

- **NCT ID:** NCT01092663
- **Lead sponsor:** KineMed
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2013-01-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01092663

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01092663, "The Effects of Co-admin of Colesevelam and Sitagliptin on Glucose Metabolism in Subjects With Type 2 Diabetes Mellitus". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01092663. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*